• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Increasing Appointment Attendance: A Vital Opportunity to Improve Health Outcomes for Those Living with Sickle Cell Disease – Webinar

Sickle cell disease (SCD) affects approximately 100,000 Americans, predominantly those of African descent. The inherited blood disorder may cause acute pain episodes, infection and other serious health problems that can affect every organ in the body.

To optimize health outcomes, national guidelines recommend routine follow-up appointments every six months, and more frequently for patients on specific therapies or experiencing complications. Yet, a recent national study showed that a majority of patients, both children and adults, reported missing a clinic appointment. This means that a majority of patients with SCD may miss out on therapies that have the potential to improve their health and quality of life.

To better understand what’s behind the high rate of missed appointments, NICHQ conducted a series of interviews with patients and providers. Now, we’re inviting all SCD stakeholders—health professionals, service providers, patients, and families—to join NICHQ for a live-webinar where we’ll share our findings and facilitate a discussion on change strategies. 


When: August 10, 2020, 3:30 PM – 4:30 PM ET


This event has ended.




To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.